Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.68 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.68 |
| ▸ | PGR | P06401 | 1/20 | 0.68 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.68 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.68 |
| ▸ | FAAH | O00519 | 4/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | F7 | P08709 | 1/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.53 |
| ▸ | F3 | P13726 | 1/20 | 0.53 |
| ▸ | RXRA | P19793 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | PPARG | P37231 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27897188 | 0.94 | ALDH1A1 (0.69) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL10037039 | 0.94 | ALDH1A1 (0.69) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL14520293 | 0.94 | ADORA3 (0.71) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL10037042 | 0.91 | FAAH (0.55) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL9905949 | 0.90 | FAAH (0.82) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL15451530 | 0.90 | FAAH (0.82) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL18237104 | 0.89 | ADORA3 (0.64) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL14079473 | 0.89 | ADORA3 (0.64) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL9905962 | 0.89 | ADORA3 (0.64) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL3195987 | 0.88 | ALDH1A1 (0.73) | ADORA3NR1I2PGRPTGS2PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230355564-A1 | CANNABINOIDS COMPOSITIONS WITH POLYUNSATURATED FATTY ACID MONOGLYCERIDES, METHODS AND USES THEREOF | SCF PHARMA INC. (CA) | 2023-11-09 | — | — | US | disclosed |
| US-11701337-B2 | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof | SCF PHARMA INC. (CA) | 2023-07-18 | — | — | US | disclosed |
| US-9925165-B2 | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof | SCF PHARMA INC. (CA) | 2018-03-27 | — | — | US | disclosed |
| US-20170014369-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2017-01-19 | — | — | US | disclosed |
| US-9101563-B2 | Method for treating an inflammatory disease with compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof | SCF PHARMA INC (CA) | 2015-08-11 | — | — | US | disclosed |
| US-8329747-B2 | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof | Centro de Recherche sur les Biotechnologies Marines (CA) | 2012-12-11 | — | — | US | disclosed |
| US-20120251582-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2012-10-04 | — | — | US | disclosed |
| US-20120213872-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2012-08-23 | — | — | US | disclosed |
| US-20120213823-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2012-08-23 | — | — | US | disclosed |
| US-8222295-B2 | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2012-07-17 | — | — | US | disclosed |
| US-8198324-B2 | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2012-06-12 | — | — | US | disclosed |
| US-8119690-B2 | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2012-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120213872-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES THEREOF AND USES THEREOF | MGLL, PNLIP, FASN | ADORA3 1652/4885NR1I2 2226/4885PGR 1781/4885 |
| US-20120251582-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | MGLL, PNLIP, FASN | ADORA3 1612/4885NR1I2 2216/4885PGR 1737/4885 |
| US-20230355564-A1 | CANNABINOIDS COMPOSITIONS WITH POLYUNSATURATED FATTY ACID MONOGLYCERIDES, METHODS AND USES THEREOF | CNR2, SGMS2, SGMS1 | ADORA3 668/4885NR1I2 921/4885PGR 1622/4885 |
| US-20170014369-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | PPARG, PTGES, PTGIS | ADORA3 1724/4885NR1I2 2641/4885PGR 4113/4885 |
| US-11701337-B2 | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof | CPT2, AGK, GSR | ADORA3 1466/4885NR1I2 2211/4885PGR 2848/4885 |
| US-20120213823-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES THEREOF AND USES THEREOF | MGLL, PNLIP, FASN | ADORA3 1652/4885NR1I2 2226/4885PGR 1781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.